Dichiarazione di accessibilità Salta la navigazione
  • Torna ai siti globali
  • +44 (0)20 7454 5110
  • GDPR
  • Giornalisti
  • Richiedi maggiori informazioni
PR Newswire: news distribution, targeting and monitoring
  • Notizie
  • Prodotti
  • Contatto
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Richiedi maggiori informazioni
    • Telefono

    • +44 (0)20 7454 5110 da 8 AM - 5 PM GMT

    • Contattaci
    • Contattaci

      +44 (0)20 7454 5110
      da 8 AM - 5 PM GMT

  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR
  • Richiedi maggiori informazioni
  • Giornalisti
  • GDPR

Fertibank at the Forefront of Genetic Studies Thanks to Agreement with Igenomix
  • Italia - Italiano
  • USA - Deutsch
  • USA - English
  • USA - Français


Notizia fornita da

Fertibank

04 nov, 2020, 10:00 GMT

Condividi articolo

Share toX

Condividi articolo

Share toX

The Barcelona egg and sperm bank has teamed up with the leading reproductive genetics laboratory to analyse all its egg and sperm donors with the CGT Exome test

The test detects DNA mutations that are associated with malformations, intellectual disability, or cardiovascular diseases in the offspring

63% of people are carriers of recessive mutations

BARCELONA, Spain, Nov. 4, 2020 /PRNewswire/ -- Fertibank egg and sperm bank has reached an agreement with the leading reproductive genetics laboratory Igenomix to analyse all its egg and sperm donors using the CGT Exome genetic test, which is the most complete and rigorous genetic compatibility and carrier test on the market.

This genetic test detects mutations in certain genes that can lead to malformations, intellectual disability, blindness, mobility and coordination problems, or cardiovascular, respiratory, and digestive diseases in the offspring of women and couples who want to have a baby with the aid of egg and/or sperm donation.

The CGT Exome test by Igenomix identifies monogenic anomalies through mass DNA sequencing. This makes it possible to analyse over 1,500 genes and detect over 30,000 mutations associated with more than 1,600 monogenic diseases in egg and sperm donor candidates.

Assisted reproduction with donor eggs

For couples undergoing assisted reproduction treatment that require egg and/or sperm donation, CGT Exome screening makes it possible to combine the genetic information of the donors with the genetic information of the couple receiving the donated gametes. This way, Fertibank will be able to select the perfect donors for all couples undergoing treatment, and identify the best genetic match to maximize their chances of having healthy offspring. We should bear in mind that approximately 63% of people are carriers of recessive mutations.

Performing this genetic screening ensures quality and safety in the donor selection processes at Fertibank, and is the best way for assisted reproduction patients to improve their chances of having genetically healthy offspring.

About Us:

Fertibank has more than twenty years of experience providing cryopreserved biological samples of the highest quality for assisted reproduction treatments, and works with numerous clinics and hospitals around the world: www.fertibank.com 

Contact:
Sergio Vicente,
+34651852995,
[email protected]

Link correlati

https://www.fertibank.com/

Modal title

Contatta PR Newswire

  • +44 (0)20 7454 5110
    da 8 AM - 5 PM GMT

Siti globali

  • APAC
  • APAC - Cinese tradizionale
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania

 

  • India
  • Indonesia
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Medio Oriente - Arabo
  • Olanda
  • Norvegia
  • Polonia

 

  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Unito
  • Stati Uniti

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Siti globali
  • Asia
  • Brasile
  • Canada
  • Ceco
  • Danimarca
  • Finlandia
  • Francia
  • Germania
  • India
  • Israele
  • Italia
  • Messico
  • Medio Oriente
  • Olanda
  • Norvegia
  • Polonia
  • Portogallo
  • Russia
  • Slovacchia
  • Spagna
  • Svezia
  • Regno Uniti
  • Stati Uniti
+44 (0)20 7454 5110
da 8 AM - 5 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2026 Cision US Inc.